Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
评价不同浓度及不同给药频率QLM3003软膏在轻中度特应性皮炎患者中的有效性
CTR20233053Phase 2Completed
- Sponsor
- Qilu Pharmaceutical
- Start
- Oct 2023
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing QLM3003 Ointment with Placebo Ointment (2 arms). Started Oct 2023; status: completed.
02
Drugs
QLM3003
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20233053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233053.